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Autophagy and vitamin D3-mediated innate immu-
nity have been shown to confer protection against
infection with intracellular Mycobacterium tubercu-
losis. Here, we show that these two antimycobacte-
rial defenses are physiologically linked via a regula-
tory function of human cathelicidin (hCAP-18/LL-37),
a member of the cathelicidin family of antimicrobial
proteins. We show that 1,25-dihydroxyvitamin D3
(1,25D3), the active form of vitamin D, induced au-
tophagy in human monocytes via cathelicidin, which
activated transcription of the autophagy-related
genes Beclin-1 and Atg5. 1,25D3 also induced the
colocalization of mycobacterial phagosomes with
autophagosomes in human macrophages in a cathe-
licidin-dependent manner. Furthermore, the antimy-
cobacterial activity in humanmacrophagesmediated
by physiological levels of 1,25D3 required autophagy
and cathelicidin. These results indicate that human
cathelicidin, a protein that has direct antimicrobial
activity, also serves as a mediator of vitamin D3-
induced autophagy.
INTRODUCTION
Mycobacterium tuberculosis (Mtb) is a major intracellular path-
ogen of humans, with an estimated one-third of the global pop-
ulation being latently infected, 2–3 million deaths annually from
tuberculosis (Dye et al., 1999), and an increasing number of
multidrug-resistant tuberculosis cases (Chan and Iseman, 2008).
Despite the multitude of immune defense mechanisms that the
host can deploy against Mtb, this bacterium persists in phago-
cytic cells because of its repertoire of escape pathways (Keane
et al., 2000; Loeuillet et al., 2006). Earlier studies suggested
that vitamin D3 exerted antimicrobial actions, i.e., a substantial
reduction in the intracellular bacterial load in human monocytes
and macrophages, against Mtb in vitro (Rook et al., 1986; Crowle
et al., 1987). A breakthrough study has paved the way to under-Cell Hoststanding vitamin D3-dependent antimicrobial mechanisms
that act through cathelicidin against human tuberculosis (Liu
et al., 2006). Additionally, adequate vitamin D3 levels are
required for cathelicidin induction and appropriate antimicrobial
activity against Mtb in humans (Liu et al., 2006, 2007). Moreover,
the 1,25-dihydroxyvitamin D3 (1,25D3)-induced antimicrobial
activity of monocytes is known to be regulated by phosphatidy-
linositol 3-kinase (PI3K) and NADPH oxidase (NOX) (Sly et al.,
2001). Recently, we reported that NOX2-derived reactive oxygen
species (ROS) play an essential role in vitamin D3-dependent
cathelicidin induction in human macrophages (Yang et al.,
2009). However, several important questions remain regarding
the mechanism(s) of action of vitamin D3-induced cathelicidin
for antimycobacterial defense in human monocytes/macro-
phages.
Autophagy, which plays important roles in the degradation of
damaged cytosolic components and misfolded proteins and in
organelle turnover (Klionsky and Emr, 2000; Ohsumi, 2001;
Scherz-Shouval and Elazar, 2007; Levine and Kroemer, 2008),
is emerging as a key factor in antimicrobial defense mechanisms
(Colombo et al., 2006; Orvedahl and Levine, 2009). In host-path-
ogen interactions, autophagy functions as a fundamental cellular
homeostasis pathway and is designed to effectively encounter
the microbial insult of the environment (Deretic, 2005; Orvedahl
and Levine, 2009). Importantly, autophagic pathways enhance
host resistance to mycobacterial infections by capturing and
destroying the immature phagosomes that harbor Mtb (Gutierrez
et al., 2004; Singh et al., 2006). Recently, it has been shown that
1,25D3 and the vitamin D3 analog EB1089 induce autophagy and
autophagic cell death in a human breast adenocarcinoma cell line
(Høyer-Hansen et al., 2005; Demasters et al., 2006). However, it
remains to be resolved whether the pleiotropic immune modu-
lator vitamin D3 can induce autophagy in normal phagocytes or
immune cells so as to promote antimicrobial activity.
There are a number of important questions relating to: (1)
whether vitamin D3 induces autophagy in human macrophages,
which serve both as host cells and effectors; and (2) the regula-
tory mechanisms that are specifically involved in macrophage
induction of autophagosomes. In the present study, using
human monocytic THP-1 cells and primary monocytes, we
demonstrated a role for 1,25D3 in autophagy induction, and& Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 231
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tion of autophagosomes and their fusion with lysosomes, leading
to optimal promotion of antimycobacterial activities. Cathelici-
dins are a family of antimicrobial defense proteins; the only
human cathelicidin identified is called human cationic antimicro-
bial protein (hCAP-18), from which LL-37 is cleaved as an active
C-terminal peptide (Cowland et al., 1995). We show that hCAP-
18/LL-37 expression is required for the enhanced induction of
autophagy-related gene expression, whereas blocking autoph-
agy does not affect 1,25D3-mediated hCAP-18/LL-37 expres-
sion. In 1,25D3-induced autophagy, hCAP-18/LL-37 is recruited
to autophagosomes in Ca2+/calmodulin-dependent kinase
kinase (CaMKK)-b-dependent and AMP-activated protein
kinase (AMPK)-dependent manners. Our findings indicate that
1,25D3 is an important inducer of autophagy through hCAP-
18/LL-37.
RESULTS
1,25D3 Triggers the Formation of Autophagosomes
and Autophagolysosomes in THP-1 Cells and Human
Primary Monocytes
It has been shown that the vitamin D analog EB1089 induces au-
tophagic cell death of breast cancer cells (Høyer-Hansen et al.,
2005). Additionally, vitamin D3 promotes autophagic responses
through the induction of Beclin-1 expression and class III PI3K
(PI3KC3) in human myeloid leukemia cells (Wang et al., 2008).
Here, we examine whether vitamin D3 induces autophagy in
human primary monocytes. Because the microtubule-associ-
ated protein 1 light chain 3 (LC3) specifically associates with au-
tophagosomes (Kabeya et al., 2000), the numbers of endoge-
nous LC3-positive vesicles reflecting autophagosomes was
monitored in primary monocytes treated with 1,25D3. As shown
in Figure 1A, LC3 aggregates were formed in human primary
monocytes after treatment with 1,25D3 for 24 hr (Figure 1A;
quantification shown at bottom). A similar effect was observed
when the THP-1 cells or RAW 264.7 cells were treated with
1,25D3 for 24 hr (Figures S1A and S1B; quantification shown
at bottom). Additionally, the numbers of LC3 vesicles were
decreased by an autophagy inhibitor, 3-methyladenine (3-MA),
which blocks the activity of PI3K and the formation of
autophagosomes (Seglen and Gordon, 1982) (Figures 1A, S1A,
and S1B). Either Beclin-1 or Atg5 levels are critically required
for autophagosome formation in mammalian cells (Liang et al.,
1999; Mizushima et al., 2001). Notably, THP-1 cells transfected
with short interfering RNA (siRNA) specific to either Beclin-1 or
Atg5 showed marked inhibition of 1,25D3-induced autophagy
(Figure 1B).
During autophagy, LC3 is processed posttranslationally into
soluble LC3-I and, in turn, converted to membrane-bound
LC3-II that correlates with the extent of autophagosomes
(Kabeya et al., 2000; Mizushima and Yoshimori, 2007). To deter-
mine the proportion of LC3 present in the LC3-II form, we per-
formed immunoblot analyses of LC3-I and LC3-II in human
monocytes and THP-1 cells. Elevated LC3-II/LC3-I ratios, similar
to those found when autophagy was induced (Kabeya et al.,
2000), were observed in the human monocytes (Figures 1C
and 1D) and THP-1 cells (Figure S1C) after treatment with
1,25D3 for 24 hr. Moreover, we obtained evidence for 1,25D3-232 Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 Elsinduced autophagy from electron microscopy, which revealed
the presence of multiple autophagosome-like vacuoles with
double-membrane structures in 1,25D3-treated cells
(Figure 1E; quantification shown at bottom). We also examined
whether 1,25D3 induced autophagosome-lysosome fusion by
staining colocalization between LC3 and lysosomes. Confocal
images show that monocytes treated with 1,25D3 exhibited
increased accumulation of the autophagosomal marker LC3
and lysosomes (stained with LysoTracker [Molecular Probes;
Eugene, OR]) in monocytes (Figure 1F). Additionally, primary
monocytes (Figure S1D) incubated with 1,25D3 significantly
accumulated autophagosomes stained with monodansyl cadav-
erine (MDC), an autofluorescent marker for autophagic vacuoles
(Biederbick et al., 1995; Scarlatti et al., 2004), and lysosomes
(stained with LysoTracker). These findings indicate that
1,25D3-induced autophagosomes are appropriately targeted
and fuse with lysosomes. Addition of the vacuolar H+-ATPase
inhibitor bafilomycin A (Baf-A) (Kabeya et al., 2000; Mizushima
et al., 2001) caused inhibition of the autophagosome-lysosome
fusion step, leading to accumulation of the autophagic vesicle
marker LC3-II (Figure 1D) and inhibition of the colocalization of
autophagosomes and lysosomes (Figure S1D) in 1,25D3-treated
cells. Thus, 1,25D3 activates both autophagy and autophago-
some-lysosome fusion in human monocytic cells and primary
monocytes.
Human Cathelicidin Is Required for 1,25D3-Induced
Autophagy Activation in Monocytes/Macrophages
Previous studies demonstrated that the host defense peptide
cathelicidin is required for 1,25D3-triggered antimicrobial activity
against intracellular Mtb (Liu et al., 2007). Although it is now
known that LL-37 has other pleiotropic functions, which include
chemotactic, endotoxin-neutralizing, angiogenic, and wound-
healing activities (Kai-Larsen and Agerberth, 2008), a role of
hCAP-18/LL-37 in the autophagy process has not been re-
ported. We questioned whether 1,25D3-dependent hCAP-18/
LL-37 expression was required for autophagy activation in
human monocytes. 1,25D3 treatment of human monocytes sig-
nificantly increased the expression of hCAP-18/LL-37 mRNA
(Figure 2A), consistent with previous results (Liu et al., 2007;
Yang et al., 2009).
To assess the role of cathelicidin in autophagy induction in
primary cells, we examined the knockdown efficiency of lentiviral
vectors for hCAP-18/LL-37 expression in primary monocytes.
Five different shRNA constructs designed for hCAP-18/LL-37
silencing and control shRNA transfection vectors were exam-
ined. After selection with puromycin, varying levels of knock-
down resulted (Figure S2A). Three of five shRNA constructs
knocked down hCAP-18/LL-37 mRNA expression by >88%.
The remaining two constructs resulted in 61% and 72% knock-
down of endogenous mRNA expression, respectively. Notably,
housekeeping genes, including b-actin, glyceraldehyde 3-phos-
phate dehydrogenase, b-tubulin, porphobilinogen deaminase,
and cyclophilin B remained unchanged after lentiviral shRNA
transduction (Figure S2B). In further experiments, we used
shRNA clone 2 (shLL-37-2, for most experiments) and clone 3
(shLL-37-3, for intracellular survival assay). Lentiviral shRNA
specific to hCAP-18/LL-37 (shLL-37) transduction to human
primary monocytes led to significant decreases in theevier Inc.
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Vitamin D3 Induces AutophagyFigure 1. 1,25D3 Induces Autophagy in Monocytes/Macrophages
(A) Human monocytes were incubated with 1,25D3 (20 nM) in the absence or presence of 3-MA (10 mM) for 24 hr, fixed, stained with DAPI to visualize the nuclei
(blue), and immunolabeled with the anti-LC3 antibody, followed by the addition of FITC-conjugated goat anti-rabbit IgG (green). Upper panel: representative
immunofluorescence images of seven independent replicates are shown; scale bars = 5 mm. Lower panel: quantitative analysis of the percentages of cells
with LC3+ punctae.
(B) Quantitative analysis of the GFP-LC3 fluorescence images. THP-1 cells were cotransfected with the GFP-LC3 construct and nonspecific (siNS) or specific
siRNAs for Beclin-1 (siBec) or Atg5 (siAtg5). All transfections were performed for 36 hr prior to 1,25D3 treatment. RT-PCR was performed to assess transfection
efficiency (inset).
(C and D) Immunoblot analyses with antibodies to LC3 or b-actin for human monocytes. Representative data are shown for the time courses (for C) and pretreat-
ment with 3-MA or Baf-A (for D). Representative gel images of three independent replicates are shown. The ratio of the intensities of the LC3-II and LC3-I bands is
indicated below each lane.
(E) Upper panel: human THP-1 cells were treated with 1,25D3 for 24 hr and subjected to TEM. Representative TEM images from two independent experiments are
shown. Lower panel: quantitative analysis of TEM. The percentage of cells with autophagic vacuoles per each section (mean ± SD; n = 200) under TEM was
calculated and summarized. N, nucleus; M, mitochondria; red arrows, autophagic vacuoles; white arrows, double-membrane structure.
(F) 1,25D3 induces colocalization of autophagosomes (endogenous LC3, red) and lysosomes (green) in human monocytes. Upper panel: representative immu-
nofluorescence images of seven independent replicates are shown; scale bars = 20 mm. Lower panel: percentages of cells that showed colocalization in the
absence or presence of Baf-A. Data shown (for A, B, and F) represent the means ± SD of seven independent samples, with each experiment including at least
200 cells scored in five random fields. ***p < 0.001, versus control conditions. U, untreated and incubated; SC, treated with solvent control (0.1% DMSO for D
and F).Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 233
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Vitamin D3 Induces AutophagyFigure 2. Human Cathelicidin Is Required for 1,25D3-Induced Autophagy
(A) Human primary monocytes were incubated with 1,25D3 (20 nM) for the indicated times, and semiquantitative RT-PCR analysis was performed for hCAP-18/
LL-37 (LL-37) or b-actin. Upper panel: a representative gel of three independent replicates is shown. Lower panel: densitometric assessment from three inde-
pendent replicates (for each experiment) with similar results.
(B) Human primary monocytes transduced with lentiviruses expressing nonspecific shRNA (shNS) or specific shRNA for LL-37 (shLL-37) were incubated in the
absence or presence of 1,25D3 (20 nM) for 18 hr. The cells then were stained with anti-LC3-TRITC (1:400). Left panel: representative immunofluorescence images
of five independent replicates are shown; scale bars = 5 mm. Right panel: quantitation of the percentage of cells with LC3 punctae. RT-PCR was performed to
assess transduction efficiency (inset).
(C) Western blot analysis using antibodies against LC3, hCAP-18/LL-37, and b-actin. The experimental conditions were as outlined in Figure 2B. A representative
gel of three independent replicates is shown. The ratio of the intensities of the LC3-II and LC3-I bands is indicated below each lane.
(D) The experimental conditions were as outlined in Figure 2B. THP-1 cells were stained with DAPI to visualize the nuclei (blue) and with LysoTracker to detect
lysosomes (green) and immunolabeled with anti-LC3-TRITC (1:400). Upper panel: representative immunofluorescence images of five independent replicates are
shown; scale bars = 10 mm. Lower panel: graph shows the number of profiles in fields. RT-PCR was performed to assess transfection efficiency (inset).
(E) Human monocytes were incubated with 1,25D3 at concentrations from 1 pM to 20 nM for 24 hr. The red box highlights the data for LC3 puncta-positive cells
incubated in the presence of physiological levels of 1,25D3 (50–100 pM). The cells were stained with anti-LC3-FITC (1:400).
(F) Induction of hCAP-18/LL-37 mRNA expression by monocytes in the presence of physiological level of 1,25D3 (100 pM). The mRNA expression was deter-
mined using quantitative RT-PCR analysis. The columns show the means ± SD of the mRNA levels from three independent replicates. Real-time PCR was per-
formed in duplicate.
(G) The experimental conditions were as outlined in Figure 2B, except that the 1,25D3 concentration was 100 pM. The figure shows the percentage of cells with
LC3 punctae. RT-PCR was performed to assess the transduction efficiency (inset). Data shown (for B, D, E, and G) represent means ± SD of five independent
samples, with each experiment involving the scoring of at least 200 cells. **p < 0.01; ***p < 0.001 versus control conditions. U, untreated and incubated.percentage of endogenous LC3 puncta-positive cells after treat-
ment with 1,25D3 when compared with nonspecific control
shRNA lentiviral particle (shNS) transduction (Figure 2B). Addi-
tionally, we transfected THP-1 cells with siRNA specific for234 Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 ElshCAP-18/LL-37 (siLL-37), which effectively silenced the hCAP-
18/LL-37 gene, but not other housekeeping genes (Figure S3A).
The hCAP-18/LL-37 knockdown in THP-1 cells markedly in-
hibited 1,25D3-induced autophagy, whereas THP-1 cellsevier Inc.
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increased formation of GFP-LC3 punctae, consistent with auto-
phagosome formation (Figure S3B). Consistent with these data,
transduction of shLL-37 or transfection with siLL-37 also signif-
icantly blocked endogenous conversion of LC3-I to LC3-II in
1,25D3-treated primary monocytes (Figure 2C) or THP-1 cells
(Figure S3C), respectively.
To further examine whether hCAP-18/LL-37 is required for
autophagosome-lysosome fusion, THP-1 cells were transfected
with siNS or siLL-37 and treated with 1,25D3 for 36 hr. 1,25D3
treatment increased the colocalization of autophagosomes
(LC3 staining) and lysosomes (LysoTracker) in siNS-transfected
THP-1 cells (Figure 2D). In contrast, hCAP-18/LL-37 silencing
significantly decreased the frequency of autophagosome-lyso-
some fusion in cell cultures treated with 1,25D3. Thus, hCAP-
18/LL-37 is required for autophagy induction and the formation
of autophagolysosomes, implicating a role of hCAP-18/LL-37
in the formation of autophagosomes and the maturation process
into autolysosomes that occurs in response to 1,25D3.
For the experiments, a 1,25D3 concentration of 20 nM was
selected because it efficiently induces cathelicidin expression
in human monocytes/macrophages and subsequent antimicro-
bial activity after infection with Mtb (Liu et al., 2006; Yang et al.,
2009). As the amount of 1,25D3 used to activate human mono-
cytes under the previous experimental conditions was much
higher than normal serum levels, we examined whether autoph-
agy is activated under physiological conditions. The data showed
robust activation of autophagy in human primary monocytes in
the presence of physiological levels of 1,25D3 (100 pM) (Fig-
ure 2E). Treatment of cells with 1,25D3 at a concentration within
the normal range in human sera led to a 7-fold increase in cathe-
licidin mRNA expression, as determined by quantitative RT-PCR
(Figure 2F). Moreover, autophagosome formation with the accu-
mulation of endogenous LC3 punctae was significantly reduced
in shLL-37-transduced primary monocytes after treatment with
physiological levels of 1,25D3, compared with those transduced
with shNS (Figure 2G). Together, these findings suggest that
vitamin D3 at physiological concentrations is sufficient to induce
autophagy in human primary monocytes.
Silencing of Human Cathelicidin Inhibits
the Enhancement of Autophagy-Related Gene
Expression but Not Vice Versa
Recently, it was reported that vitamin D3 enhances the expres-
sion of Beclin-1 and induces the expression of PI3KC3 in
leukemia cells (Wang et al., 2008). To test whether cathelicidin
is involved in the enhanced expression of autophagy-related
genes in human macrophages, the transcripts for the mamma-
lian autophagy-essential proteins Beclin-1 and Atg5 were
analyzed by real-time and semiquantitative RT-PCR after
1,25D3 treatment. The Beclin-1 and Atg5 genes were expressed
constitutively by monocytes (Figure 3A). Increased expression
levels of Beclin-1 and Atg5 of mRNA were observed from 3 hr
after treatment with 1,25D3 (Figure 3A). A 10-fold increase in Be-
clin-1 mRNA was observed at 6 hr (Figure 3A). Silencing with
siLL-37 caused significant reductions in the Beclin-1 and Atg5
mRNA levels (2- to 3-fold reduction at 24 hr) (Figure 3C), which
suggests that hCAP-18/LL-37 is essential for 1,25D3-mediated
induction of autophagosome formation. In contrast, 1,25D3-Cell Host &mediated hCAP-18/LL-37 mRNA expression was not inhibited
in cells that were pretreated with 3-MA or Wortmannin, both of
which are inhibitors of PI3K (Gutierrez et al., 2004) (Figure 3B).
We confirmed these data using siRNA silencing of Beclin-1 or
Atg5 in THP-1 cells. Neither Beclin-1 nor Atg5 deficiency
affected hCAP-18/LL-37 gene or protein expression in THP-1
cells in the presence of 1,25D3 (Figures 3D and 3E), which indi-
cates that human cathelicidin is induced and modulates autoph-
agy, but not vice versa.
1,25D3-Mediated Beclin-1 and Atg5 Transcriptional
Activation Is Mediated through hCAP-18/LL-37-
Dependent C/EBPb and MAPK Activation
We further investigated the molecular mechanisms of hCAP-18/
LL-37-dependent Beclin-1 and Atg5 transcriptional activation.
As we demonstrated that 1,25D3-mediated Beclin-1 and Atg5
transcription is dependent on hCAP-18/LL-37, we next investi-
gated whether hCAP-18/LL-37 modulates the promoter activi-
ties of genes Beclin-1 or Atg5. Consistent with our earlier obser-
vations, 1,25D3 stimulated Beclin-1 (pGL3-BECL1-1P) or Atg5
(pGL3-ATG5-1P) promoter reporter activities, and hCAP-18/
LL-37 silencing significantly blocked these effects (Figure 4A).
A search for putative DNA binding sites for transcription fac-
tors in the regulatory sequences of human ATG5 and Beclin-1
was conducted using the programs TFSEARCH (http://www.
cbrc.jp/research/db/TFSEARCH.html) and MOTIF Search (http://
motif.genome.jp). As both gene promoter regions have CCAAT/
enhancer binding protein (C/EBP) b-binding sites, we examined
whether 1,25D3-dependent transcriptional activation of C/EBPb
was modulated by hCAP-18/LL-37. The data show that the
enhancement of 1,25D3-dependent C/EBPb luciferase activities
in siNS-transfected control cells was significantly inhibited by
siLL-37 transfection (Figure 4B). However, 1,25D3-dependent
nuclear factor (NF)-kB p65 luciferase activities were not signifi-
cantly affected by siLL-37 transfection (Figure 4B). Additionally,
siRNA transfection of C/EBPb (siC/EBPb) markedly inhibited
mRNA expression and reporter gene activities of Beclin-1 and
Atg5 in THP-1 cells in response to 1,25D3, whereas transfection
of siNS did not (Figures 4C and 4D for mRNA expression and
promoter-reporter activity, respectively). In contrast, mRNA
expression or reporter gene activities of Beclin-1 and Atg5
were not significantly different in WT and p65/ mouse embry-
onic fibroblasts (MEFs) (Figures S4A and S4B for mRNA expres-
sion and promoter-reporter activity, respectively). Moreover,
deletion constructs lacking two C/EBPb binding sites of genes
Beclin-1 (pGL3-BECL1-3P) and Atg5 (pGL3-ATG5-3P) were
generated (Figure S4C, left). Transfection of these deletion
constructs and treatment with 1,25D3 showed that 1,25D3-
induced Beclin-1 and Atg5 promoter-reporter activity was signif-
icantly attenuated by the deletion of C/EBP binding sites
(Figure S4C, right).
We further showed that 1,25D3-dependent p38 mitogen-acti-
vated protein kinase (MAPK) and extracellular signal-regulated
kinase (ERK) 1/2 activation were profoundly decreased in siLL-
37-transfected cells (Figures 4E and 4F). Moreover, blockade
of p38 and ERK1/2 but not c-Jun N-terminal kinases activities
markedly inhibited the Beclin-1 or Atg5 mRNA expression
(Figure 4G) and reporter gene activity (Figure S4D). Together,
these data suggest that 1,25D3-dependent Beclin-1 and Atg5Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 235
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Vitamin D3 Induces AutophagyFigure 3. Human Cathelicidin Is Required for 1,25D3-Mediated Expression of Autophagy-Related Genes
(A and B) Quantitative real-time PCR analysis was performed for the indicated genes. Human monocytes were incubated with 1,25D3 (20 nM) for indicated time
periods (A) or pretreated with 3-MA (2 hr, 10 mM) or Wortmannin (WM; 1 hr, 100 nM) before incubation with 1,25D3 for 6 hr (B). The columns show the means ± SD
of the mRNA levels from three independent experiments. Real-time PCR was performed in duplicate.
(C and D) THP-1 cells transfected with nonspecific siRNA (siNS) or siRNA specific for hCAP-18/LL-37, Beclin-1, or Atg5 (siLL-37, siBec, or siAtg5, respectively)
were incubated with 1,25D3 for 6 hr. Left panel: the columns show the means ± SD of the mRNA levels from three independent experiments. Real-time PCR was
performed in duplicate. Right panel: representative gel images of three independent replicates are shown.
(E) The experimental conditions were as outlined in Figure 3D. THP-1 cells were stained with DAPI to visualize the nuclei (blue) and also stained with anti-hCAP-18/
LL-37-PE (1:400). Left panel: representative immunofluorescence images; scale bars = 25 mm. Right panel: relative fluorescence intensities presented as the
mean ± SD of three independent experiments, with each experiment involving the scoring of at least 200 cells. ***p < 0.001, versus control conditions. U, untreated
and incubated; SC, treated with solvent control (0.1% DMSO); LL-37, hCAP-18/LL-37.transcriptional activation is mediated through hCAP-18/LL-37-
dependent activation of C/EBPb and MAPKs.
1,25D3 Induces the Recruitment of hCAP-18/LL-37
to Autophagosomes through the Ca2+/CaMKK-b- and
AMPK-Dependent Pathways
We next investigated intracellular trafficking of hCAP-18/LL-37 in
response to 1,25D3. Untreated THP-1 cells or monocytes
showed relatively scarce staining of autophagosomal structures
and diffuse cytoplasmic hCAP-18/LL-37 staining (Figures 5A and
5B, untreated). Treatment of THP-1 cells and human monocytes
with 1,25D3 resulted in the accumulation of punctate autopha-
gosome structures, which colocalized with endogenous hCAP-
18/LL-37 expression, as visualized by immunofluorescence
(Figures 5A and 5B for THP-1 cells and monocytes, respectively).
These data suggest that 1,25D3-induced hCAP-18/LL-37 is
recruited to autophagosomes.236 Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 ElsThe signaling pathways that involve Ca2+/CaMKK-band AMPK
play essential roles in Ca2+-dependent induction of autophagy
(Høyer-Hansen and Ja¨a¨ttela¨, 2007). We hypothesized that
these pathways regulate 1,25D3-induced autophagy activation
through hCAP-18/LL-37 recruitment into autophagosomal struc-
tures. In agreement with previous findings (Høyer-Hansen and
Ja¨a¨ttela¨, 2007), 1,25D3-induced autophagy is modulated
through intracellular free Ca2+, CaMKK-b, and AMPK (Figure S5).
We also investigated whether hCAP-18/LL-37 colocalization
with autophagosomes was dependent on these pathways. As
shown in Figure 5C, the colocalization of hCAP-18/LL-37 with
autophagosomes (endogenous LC3 staining) in 1,25D3-treated
cells was dose-dependently decreased by pretreatment with
specific inhibitors, including an intracellular calcium-specific
chelator (1,2-bis[2-aminophenoxy]ethane-N,N,N0,N0-tetraacetic
acid-acetoxymethyl ester) (BAPTA-AM), a CaMKK-a/b in-
hibitor (STO-609), or an ATP-competitive inhibitor of AMPKevier Inc.
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Vitamin D3 Induces AutophagyFigure 4. 1,25D3-Mediated Beclin-1 and Atg5 Transcriptional Activation Is Mediated through hCAP-18/LL-37-Dependent MAPK and
C/EBPb Activation
(A) THP-1 cells were cotransfected with nonspecific (siNS) or specific siRNAs for hCAP-18/LL-37 (siLL-37), together with a pGL3 basic, pGL3-BECN1-1P (BECN-
1P), or pGL3-ATG5-1P (ATG5-1P) luciferase reporter construct. Upper panels: RT-PCR analysis to assess transfection efficiency. Lower panel: the columns show
the means ± SD of three independent experiments. Each experiment was performed in triplicate.
(B) THP-1 cells were cotransfected with siNS or siLL-37, together with a pGL3 basic, C/EBP (C/EBPLuc), or NF-kB p65 luciferase reporter construct (p65-Luc).
After 36 hr, cells were treated with 1,25D3 for 6 hr, and then luciferase assay was performed. The luciferase activity was measured and normalized to b-galac-
tosidase activity. The columns show the means ± SD of three independent experiments. Each experiment was performed in triplicate.
(C) THP-1 cells transfected with siNS or siRNA specific for C/EBPb were incubated with 1,25D3 for 6 hr. Then real-time RT-PCR analysis was performed for Be-
clin-1 and ATG5, and data were normalized to b-actin. The columns show the means ± SD of the mRNA levels from three independent experiments. Real-time
PCR was performed in duplicate.
(D) THP-1 cells were cotransfected with specific siRNAs for C/EBPb, together with a pGL3 basic, pGL3-BECN1-1P (BECN-1P), or pGL3-ATG5-1P (ATG5-1P)
luciferase reporter construct. Upper panels: RT-PCR analysis to assess transfection efficiency. Lower panel: the columns show the means ± SD of three inde-
pendent experiments. Each experiment was performed in triplicate.
(E and F) THP-1 cells (for E) or THP-1 cells transfected with siNS or siLL-37 (for F) were incubated with 1,25D3 (for E, indicated times; for F, 30 min). The cells were
harvested and subjected to western blotting analysis for phosphorylated p38 and ERK and blotted for b-actin as a loading control. The gel images are represen-
tative of three independent experiments with similar results.
(G) The p38 MAPK inhibitor SB203580 (SB, 5 mM) or MEK inhibitor PD98059 (PD, 10 mM) was added to THP-1 cells at 45 min before stimulating with 1,25D3. After
6 hr, total RNA was collected, and real-time RT-PCR analysis of Beclin-1 and ATG5 was performed and normalized for b-actin. ***p < 0.001, versus control condi-
tions. The columns show the means ± SD of the mRNA levels from three independent experiments. Real-time PCR was performed in duplicate. U, untreated and
incubated; SC, treated with solvent control (0.1% DMSO); LL-37, hCAP-18/LL-37.Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 237
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Vitamin D3 Induces AutophagyFigure 5. HumanCathelicidin Is Recruited into Autophagosomes after 1,25D3 Treatment through the Ca2+/CaMKK-b- and AMPK-Dependent
Pathways
(A and B) Confocal microscopy analysis of the colocalization of autophagosomes and hCAP-18/LL-37 in THP-1 cells (A) and human primary monocytes (B).
Endogenous LC3 and hCAP-18/LL-37 colocalization was visualized using anti-LC3-FITC (1:400) and anti-hCAP-18/LL-37-PE (1:400) antibodies. The nuclei
were stained with DAPI (blue). Upper panel: representative immunofluorescence images of five independent replicates; scale bars = 5 mm. Lower panel: percent-
ages of cells showing colocalization of autophagosomes and hCAP-18/LL-37.
(C) Human monocytes were treated with 1,25D3 in the absence or presence of BAPTA (BAP; 5, 10, and 25 mM), STO-609 (STO; 5, 10, and 25 mM) or Compound C
(Comp C; 5, 10, and 25 mM). Colocalization between autophagosomes and hCAP-18/LL-37 was determined by immunostaining, as described in Figure 5B. The
percentages of cells showing colocalization of LC3 and hCAP-18/LL-37 are indicated.
(D) Effects on hCAP-18/LL-37 expression of inhibitors of CaMKK-b and AMPK. The experimental conditions were as outlined in Figure 5C. Human primary mono-
cytes were stained with the anti-hCAP-18/LL-37-PE (1:400) antibody. Upper panel: representative immunofluorescence images of three independent replicates;
scale bars = 10 mm. Lower panel: relative fluorescence intensities are presented as the mean ± SD of three independent experiments.
(E) THP-1 cells were transfected with siNS or siRNA specific for CaMKK-b or AMPK (siCaM or siAMPK, respectively) as indicated. Colocalization between
autophagosomes and hCAP-18/LL-37 was determined by immunostaining, as described in Figure 5B. The graph shows the percentages of LC3- and hCAP-
18/LL-37-positive cells. RT-PCR was performed to assess transfection efficiency (inset). Quantitative data in (A), (B), (C), and (E) show the means ± SD of five
independent experiments, with each experiment including at least 200 cells scored in five random fields. *p < 0.05; ***p < 0.001, versus control conditions. U,
untreated and incubated; SC, treated with solvent control (0.1% DMSO); LL-37, hCAP-18/LL-37.(Compound C). These pharmacologic inhibitors did not suppress
hCAP-18/LL-37 expression in human monocytes (Figure 5D).
Experiments using siRNA for CaMKK-b and AMPK confirmed
the results obtained with the pharmacologic inhibitors (Fig-
ure 5E). These data indicate that the CaMKK-b and AMPK path-
ways are important not only for autophagy induction but also for
hCAP-18/LL-37 recruitment into autophagosomes after 1,25D3
treatment.238 Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 Els1,25D3 Treatment Enhances Mycobacterial
Colocalization with Autophagosomes through
Cathelicidin
Previous studies demonstrated that the induction of autophagy
resulted in increased colocalization of mycobacterial phago-
somes with autophagosomes (Gutierrez et al., 2004; Singh
et al., 2006; Xu et al., 2007). Thus, we next investigated whether
1,25D3 affected the colocalization of autophagosomes withevier Inc.
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Vitamin D3 Induces AutophagyFigure 6. Human Cathelicidin Is Required for 1,25D3-Induced Colocalization of Mycobacteria with Autophagosomes
(A and B) Human MDMs were infected with FITC-Mtb for 4 hr (A). Before infection with Mtb, the THP-1 cells were transfected with nonspecific siRNA (siNS) or
siRNA specific for hCAP-18/LL-37 (siLL-37) (B). After washing, the cells were incubated in the presence or absence of 1,25D3 for 30 hr. The cells were fixed, and
autophagic vacuoles were stained with MDC (blue). The cells were then subjected to confocal microscopy to detect Mtb colocalization with autophagosomes. In
(A), left: representative fluorescence-merged images showing colocalization of Mtb (green) and autophagosomes (MDC, blue); scale bars = 5 mm. In (A), right, and
(B): quantitative data show the means ± SD of four independent experiments, with each experiment including at least 200 internalized mycobacteria scored in
seven random fields. *p < 0.05; ***p < 0.001, versus control conditions.
(C) Ultrastructural analysis of Mtb colocalization with autophagosomes in THP-1 cells in the presence or absence of 1,25D3. The data are obtained from
a minimum of 50 independent sectioned cells. Left panel: representative TEM images of two independent replicates; scale bars = 0.2 mm. Right panel: quanti-
tation of 200 internalized mycobacteria per experimental condition (mean ± SD; ***p < 0.001, versus control conditions).mycobacterial phagosomes in human monocyte-derived macro-
phages (MDMs). As shown in Figure 6A, 1,25D3 treatment signif-
icantly increased the colocalization of Mtb-containing phago-
somes with the autophagic vacuoles of human MDMs, as
compared to control cultures in medium that lacked 1,25D3.
Moreover, silencing of hCAP-18/LL-37 significantly decreased
the colocalization of Mtb-containing phagosomes and autopha-
gic structures in THP-1 cells that were incubated with 1,25D3
(Figure 6B). Human THP-1 cells that were infected with Mtb
were also examined by transmission electron microscopy (TEM)
(Figure 6C). The ultrastructural analysis revealed that Mtb-
infected THP-1 cells treated with 1,25D3 exhibited double-
membrane or onion-like structures that contained Mtb bacilli
(autophagosome-like structures), resembling the previously
described Toll-like receptor (TLR) 4-induced autophagosomes
that colocalized with mycobacterial phagosomes (Xu et al., 2007).
Autophagy Activation Is Required for 1,25D3-Mediated
Antimicrobial Activity in Human Macrophages
We next investigated whether the intracellular colocalization of
autophagosomes with mycobacterial phagosomes affected
antimycobacterial activity. Thus, we examined whether the anti-
microbial effect induced by 1,25D3 treatment could be coun-Cell Hostteracted by treatment with autophagy inhibitors 3-MA and Wort-
mannin. Notably, both 3-MA and Wortmannin blocked the
1,25D3-induced antimicrobial activity, as evidenced by the
colony forming unit (cfu) assay (Figures 7A and S6 for human
MDMs and THP-1 cells, respectively). Additionally, 1,25D3-
treated MDMs transduced with shLL-37 showed significant inhi-
bition of antimycobacterial activity, as compared to cells trans-
duced with shNS (Figure 7B). Pretreatment with 3-MA or Wort-
mannin considerably increased the viability of the intracellular
bacteria in MDMs that were transduced with shNS, whereas it
did not affect the intracellular survival of bacteria in MDMs trans-
duced with shLL-37 (Figure 7B). Moreover, THP-1 cells trans-
fected with the pcDNA-LL-37 significantly enhanced the antimy-
cobacterial activity in response to 1,25D3 as compared to those
transfected with the mock control vector (Figure 7C). It is note-
worthy that, in the presence of 3-MA or Wortmannin, the viability
of the intracellular bacteria was reduced by 45%–70% in the
THP-1 cells that were transfected with the pcDNA-LL-37 as
compared to cells transfected with the mock control (Figure 7C).
We then determined whether antimicrobial effects occur in
human MDMs under physiological conditions via vitamin D3-
cathelicidin-mediated autophagy activation. Treatment of MDMs
with a physiological concentration (100 pM) of 1,25D3& Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 239
Cell Host & Microbe
Vitamin D3 Induces AutophagyFigure 7. Autophagy Activation Plays a Critical Role in 1,25D3-Mediated Antimicrobial Activity in Human Macrophages
(A) Human primary MDMs were pretreated with SC, 3-MA (2 hr, 10 mM), or Wortmannin (WM; 1 hr, 100 nM), followed by Mtb infection (at mois of 0.1, 1, and 10). At
4 hr postinfection, the cells were washed to remove extracellular bacteria and treated with 1,25D3 (20 nM) for 3 days. Thereafter, intracellular bacteria were har-
vested and assayed for viability based on the number of cfus. The cfu data shown represent the mean ± SD of four individual experiments (***p < 0.001 for SC
versus 3-MA or WM).
(B and C) Human primary MDMs were transduced with shNS or shLL-37 for 3 days (B), or THP-1 cells were transfected with pcDNA-LL-37 or empty vector for 24
hr (C). Cells were then pretreated with SC, 3-MA (10 mM, 2 hr), or WM (100 nM, 45 min) before the addition of Mtb (moi = 1). After infection, the cells were treated
with 1,25D3 (20 nM) for 3 days and then subjected to the cfu assay. The data are representative of nine independent experiments that gave similar results. Upper
panel: RT-PCR analysis for hCAP-18/LL-37 using lysates of 53 105 cells for each transductant (B: shNS, nonspecific shRNA; shLL-37, specific shRNA for hCAP-
18/LL-37) or transfectant (C: mock, mock vector-transfected; LL-37, pcDNA-LL-37-transfected). The data included in the subfigures are the medians, interquar-
tile ranges, and 95% confidence intervals.
(D) Human MDMs were infected with Mtb and treated with 100 pM or 20 nM 1,25D3 for 3 days. Following treatment, the intracellular bacteria were harvested, and
their viability was assayed using a cfu assay. The cfu data are the mean ± SD of four individual experiments (***p < 0.001 for PBS versus 1,25D3 at 100 pM or
20 nM).
(E) The experimental conditions were as outlined in Figure 2B, except that the 1,25D3 concentration was 100 pM. The cfu data are the mean ± SD of four individual
experiments (***p < 0.001 for SC versus 3MA or WM). SC, treated with solvent control (0.1% DMSO); LL-37, hCAP-18/LL-37.significantly reduced the viability of Mtb, to levels similar to those
treated with 20 nM 1,25D3 (Figure 7D). Furthermore, shLL-37
transduction completely blocked the 1,25D3-mediated antimy-
cobacterial activity in MDMs compared to those transduced
with shNS (Figure 7E). Pretreatment of cells with 3-MA or Wort-
mannin significantly increased the intracellular survival of
bacteria in shNS-transduced MDMs with physiological levels
(100 pM) of 1,25D3, whereas it had no significant effect on
MDMs transduced with shLL-37 (Figure 7E). These data indicate
that autophagy activation is important in 1,25D3-mediated anti-
microbial activity in human macrophages. In addition, 1,25D3-
induced cathelicidin expression may contribute to macrophage
defenses against Mtb via the regulation of autophagy.240 Cell Host & Microbe 6, 231–243, September 17, 2009 ª2009 ElsDISCUSSION
Our results demonstrate a relationship between 1,25D3-induced
innate defense and autophagy activation, which may contribute
to antimycobacterial immunity. In addition, the present study
establishes human cathelicidin as a key mediator of 1,25D3-
induced autophagy and provides mechanistic insight into the
role of cathelicidin in combating Mtb. Importantly, under physio-
logical conditions, 1,25D3-induced cathelicidin appears neces-
sary to activate autophagy and induce antimicrobial activity
against Mtb. Autophagy is an important host defense mecha-
nism of murine and human macrophages against Mtb (Gutierrez
et al., 2004). Indeed, previous studies have shown autophagyevier Inc.
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et al., 2007), serum starvation, or rapamycin treatment (Gutierrez
et al., 2004). Previous studies focused on the autophagic induc-
tion of vitamin D3 primarily in cancer cells (Høyer-Hansen et al.,
2005; Demasters et al., 2006; Wang et al., 2008), indicating the
potential for vitamin D3 as an anticancer drug. However, it has
been an open question as to whether vitamin D3 can induce au-
tophagy and, consequently, antimicrobial activity, especially in
human macrophages (Liu and Modlin, 2008). In the present
study, we demonstrate that 1,25D3 induces autophagy activa-
tion and autophagolysosome formation in human primary mono-
cytes/macrophages. Recent studies using human myeloid
leukemia cells have shown that vitamin D3 triggers autophagic
death by upregulating Beclin-1 and triggering differentiation
(Wang et al., 2008). In addition, the chemotherapeutic vitamin
D analog EB1089 kills breast cancer cells by triggering nuclear
apoptosis via Beclin-1-dependent autophagy (Høyer-Hansen
et al., 2005). However, in our system, the cell death-inducing
effects of 1,25D3 for primary monocytes or THP-1 cells were
not observed until Day 3 (see Figure S7), suggesting that the
1,25D3-induced autophagy of immune cells may be related to
cell protection. Thus, the regulation of cell survival/death by
vitamin D3 seems to be controlled by cell type-specific mecha-
nisms. The cell survival and death induced by autophagy may
depend on the organism, cell type, and cell-specific conditions
(Baehrecke, 2005).
To date, numerous biologic functions have been reported for
cathelicidin, including broad-spectrum antimicrobial effects,
chemotaxis, regulation of inflammatory responses, angiogenesis,
and wound healing (Nijnik and Hancock, 2009). In the present
report, we identify an important role for cathelicidin as a critical
mediator of 1,25D3-induced autophagy induction, i.e., the regula-
tion of expression of the autophagy-related genes Beclin-1 and
Atg5. In addition, hCAP-18/LL-37 appears to be important for
the autophagy maturation process, as we found it to be essential
for autophagosome-lysosome fusion. Given that hCAP-18/LL-37
acts as a secondary messenger to promote a variety of activities
in innate and adaptive immunity (Kai-Larsen and Agerberth,
2008), our data indicate an additional novel function of hCAP-
18/LL-37 as an important messenger for 1,25D3-induced regu-
lation of autophagy. Moreover, cathelicidin is induced and
modulated upstream of autophagy. We provide evidence that
hCAP-18/LL-37 plays an important role in activation of MAPKs
and C/EBPb, which, in turn, contribute to the transcriptional
activation of Beclin-1 or Atg5 in monocytes in response to 1,25D3.
C/EBPb is known to be required for 1,25D3-induced monocytic
differentiation and appears to be under the control of the vitamin
D receptor and MAPK-transduced signals (Ji and Studzinski,
2004). It has been reported that a dual phosphorylation initiated
with a priming phosphorylation of C/EBPb by MAPK facilitates
dimerization of C/EBPb monomers, leading to the acquisition of
DNA-binding activity (Li et al., 2007; Kim et al., 2007). These
data collectively indicate that hCAP-18/LL-37 is important for
the regulation of the early stages of autophagy activation, through
modulation of autophagy-related gene expression. This function
of cathelicidin appears to be unique in terms of the control of
1,25D3-induced autophagy, as hCAP-18/LL-37 did not affect
starvation- or rapamycin-induced autophagy activation or anti-
mycobacterial effects (see Figure S8).Cell HostThe current data show that cathelicidin is recruited to the
autophagosomes of human monocytes. Similar to other catheli-
cidins, human cathelicidin is stored intact in the specific granules
of human neutrophils as a 19 kDa protein, which contains both
the conserved N-terminal cathelin-like region and the highly vari-
able C-terminal region with bactericidal activity (Cowland et al.,
1995). In general, the cathelin-like segment of antibacterial
cationic proteins appears to be essential for subcellular traf-
ficking through the synthetic apparatuses (ER, Golgi complex,
and trans-Golgi network) (Liu and Ganz, 1995). Previous studies
demonstrated that human cathelicidin is synthesized in myeloid
cells and comobilized into specific granules with lactoferrin (Sør-
ensen et al., 1997). We found that, during autophagy, cathelicidin
is synthesized and recruited to the autophagosomes by previ-
ously undescribed mechanisms. Our present results suggest
that colocalization of hCAP-18/LL-37 with autophagosomes
requires intracellular calcium influx, CaMKK-b, and AMPK.
Previous studies demonstrated that both CaMKK-b and AMPK
play essential roles in Ca2+-dependent autophagy induction
(Høyer-Hansen and Ja¨a¨ttela¨, 2007). In addition, AMPK inhibits
the mammalian target of rapamycin complex 1 and autophagy
in the nonstarved condition and, therefore, it may play a role as
a general regulator of autophagy induction in response to
Ca2+-dependent signaling (Høyer-Hansen and Ja¨a¨ttela¨, 2007).
Combining the previous and current data, it seems likely that
the CaMKK-b- and AMPK-dependent pathways contribute to
modulation of the intracellular trafficking pathways of cathelici-
din as well as to autophagy induction in human monocytes/
macrophages in response to 1,25D3.
Currently, research efforts are focused on the signals that gov-
ern autophagosome sequestration of pathogens, pathogen-
containing vesicles, microbial proteins, and genetic materials
(Deretic, 2005). Recent studies have demonstrated that the
ancient innate pathways, e.g., the sensing of pathogens via
TLRs (Delgado et al., 2008) and phagocytosis (Sanjuan et al.,
2007), are connected with the autophagy pathways. In the cur-
rent study, we show that 1,25D3-induced autophagy enhances
the colocalization of mycobacterial phagosomes and autopha-
gosomes in an hCAP-18/LL-37-dependent manner. Similarly,
previous studies have shown that lipopolysaccharide-induced
autophagy enhances mycobacterial colocalization with auto-
phagosomes (Xu et al., 2007). Our present data indicate that
1,25D3-dependent autophagy activation promotes the matura-
tion of mycobacterial phagosomes in a cathelicidin-dependent
fashion while concomitantly suppressing mycobacterial survival.
Previously, cathelicidin was shown to be important for vitamin
D3-mediated antimicrobial action during mycobacterial infection
(Liu et al., 2006, 2007; Yang et al., 2009). The current results
extend our previous finding that NOX2-dependent induction of
cathelicidin in 1,25D3-treated human macrophages contributes
to the antimycobacterial activities (Yang et al., 2009) and suggest
a host defense mechanism in which the vitamin D3-mediated
antimicrobial responses are executed through a cathelicidin-
dependent autophagy pathway.
Collectively, the current study describes a link between
autophagy and vitamin D3-induced innate immunity, both of which
target the intracellular pathogen for eradication. We believe that
these new insights offer the potential for autophagy-related ther-
apies whereby innate immune responses are generated against& Microbe 6, 231–243, September 17, 2009 ª2009 Elsevier Inc. 241
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Vitamin D3 Induces Autophagynot only tuberculosis, but also a variety of human diseases (Lev-
ine and Kroemer, 2008), including neurodegenerative disorders
with pathogenetic profiles that are potentially associated with
defective autophagy and vitamin D3 insufficiency.
EXPERIMENTAL PROCEDURES
Cell Culture
This study was approved by the Bioethics Committee of Chungnam University
Hospital, which oversees studies that use samples from human subjects.
Human monocytes were prepared as described previously (Yang et al.,
2009). Human primary monocytes, MDMs, and THP-1 and RAW 264.7 cells
were prepared as described previously (Yang et al., 2009). Details of the cells,
bacteria, chemicals, antibodies, and plasmids used are provided in Supple-
mental Data.
RNA Extraction, Real-Time and Semiquantitative RT-PCR, Western
Blotting, and Transfection
RNA extraction, real-time quantitative PCR, and semiquantitative RT-PCR
were performed as described previously (Lee et al., 2009; Liu et al., 2007).
For western blot analysis, the primary antibodies were used at 1:1000 dilu-
tions. The membranes were developed using a chemiluminescence assay
(ECL; Pharmacia-Amersham; Piscataway, NJ) and subsequently exposed to
chemiluminescence film (Pharmacia-Amersham). The primers used in this
study are summarized in Table S1.
Transfections
Transfections of plasmids and/or siRNAs into the indicated cells were per-
formed using Lipofectamine 2000 (Invitrogen; Carlsbad, CA) according to
the manufacturer’s instructions.
Autophagy Analysis
Autophagy was assessed in 1,25D3-treated cells by LC3 redistribution and
conjugation, as described previously (Xu et al., 2007; Delgado et al., 2008;
Sun et al., 2008). For the quantitation of autophagy, the percentages of
GFP-LC3-positive autophagic vacuoles in transfected cells or the numbers
of endogenous LC3 punctate dots in primary cells were evaluated using fluo-
rescence microscopy. Endogenous LC3 conjugation was evaluated by
western blot analysis using an antibody against LC3-I/II. MDC was used as
an additional tracer of autophagic vacuoles. As positive controls for the
autophagy induction experiments, cells were starved or treated with rapamy-
cin. For starvation, cells were washed three times with PBS and incubated in
EBSS for 4 hr at 37C. For rapamycin treatment, cells were incubated in
complete medium that contained 500 nM rapamycin (Sigma; St. Louis) for
12 hr. Details of the fluorescence microscopy and TEM analyses are provided
in Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, eight figures, and one table and can be found online at
http://www.cell.com/cell-host-microbe/supplemental/S1931-3128(09)00283-2.
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